The collaboration between CORONA and Ferring will cater to patients across India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
New agreement applies to the polymers of the Medical Care series portfolio
The partnership will capitalize on the combined capabilities of the two organizations
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Bridging the gap between histopathology and molecular pathology
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Subscribe To Our Newsletter & Stay Updated
